NCT00649610 - Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain | Biotech Hunter

Enrollment

340

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

May 31, 2003

Conditions

Low Back Pain

Interventions

DRUG

valdecoxib

valdecoxib 40 mg QD for 7 days with a second dose of 40 mg the first day

DRUG

diclofenac

diclofenac 75 mg twice daily (BID) for 7 days

Trial Locations (29)

1020

Pfizer Investigational Site, Caracas

1051

Pfizer Investigational Site, Caracas

1070

Pfizer Investigational Site, Caracas

7051

Pfizer Investigational Site, Cartago

45040

Pfizer Investigational Site, Zapopan

45200

Pfizer Investigational Site, Zapopan

50080

Pfizer Investigational Site, Toluca

72000

Pfizer Investigational Site, Puebla City

72070

Pfizer Investigational Site, Puebla City

72410

Pfizer Investigational Site, Puebla City

Unknown

Pfizer Investigational Site, Bs. As.

Pfizer Investigational Site, Curitiba

Pfizer Investigational Site, Santiago

Pfizer Investigational Site, Bogotá

Pfizer Investigational Site, Bogota D.C

Pfizer Investigational Site, Cali-valle

Pfizer Investigational Site, Quito

Pfizer Investigational Site, Caracas

C1221ACI

Pfizer Investigational Site, Buenos Aires

74085-450

Pfizer Investigational Site, Goiânia

80430-210

Pfizer Investigational Site, Curitiba

25620-040

Pfizer Investigational Site, Petrópolis

04023-900

Pfizer Investigational Site, São Paulo

04029-000

Pfizer Investigational Site, São Paulo

05001-000

Pfizer Investigational Site, São Paulo

05403-012

Pfizer Investigational Site, São Paulo

476-1002

Pfizer Investigational Site, Hatillo Centro

LIMA 11

Pfizer Investigational Site, Lima

LIMA 27

Pfizer Investigational Site, Lima